ANTI-HUMAN GLOBULIN (COOMBS) - ANVISA Registration 81034870009
Access comprehensive regulatory information for ANTI-HUMAN GLOBULIN (COOMBS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81034870009 and manufactured by SCAN DIAGNÓSTICA INDÚSTRIA E COMÉRCIO LTDA. The registration is held by SCAN DIAGNÓSTICA INDÚSTRIA E COMÉRCIO LTDA with validity until Oct 15, 2028.
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including DIAMED GMBH, ORTHO CLINICAL DIAGNOSTICS, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
81034870009
25351289130201860
18520715000130
Company Information
Dates and Status
Oct 15, 2018
15/10/2028
09/18/2025 19:00:01
GLOBULINA ANTI-HUMANA (COOMBS)
Anti-Human-Globulin Color
BIO-RAD LABORATORIOS BRASIL LTDA.
80020690457
Jul 14, 2025
GLOBULINA ANTI-HUMANA (COOMBS)
Anti-Human-Globulin Color
BIO-RAD MEDICAL DIAGNOSTICS GMBH
80020690457
Jul 14, 2025
GLOBULINA ANTI-HUMANA (COOMBS)
ID-LISS/Coombs
BIO-RAD LABORATORIOS BRASIL LTDA.
80020690460
Jul 14, 2025
GLOBULINA ANTI-HUMANA (COOMBS)
ID-DC Screening I
DIAMED GMBH
80020690456
Jul 14, 2025
GLOBULINA ANTI-HUMANA (COOMBS)
ID-DC Screening I
Not specified
80020690456
Jul 14, 2025

